Origin Sciences Limited in London, EC4M 7RD

Description

Data updated on: 01-11-2023

Origin Sciences Limited is a Private Limited Company, based in First Floor, 5 Fleet Place, London. The company's zip code is EC4M 7RD. The company has existed twenty one years in the UK. Its reg. no. is 04966495. The firm has operated under three different names. The first name, Colonix, was switched on 2006-09-20 to Colonix Medical. The current name is used since 2010, is Origin Sciences Limited. The firm's declared SIC number is 72190 and their NACE code stands for Other research and experimental development on natural sciences and engineering. 2022/11/30 is the last time when company accounts were reported.

At the moment, the directors enumerated by the limited company are as follow: Shane H. designated to this position in 2022 in June, Michael H. designated to this position 2 years ago, Hugo L. designated to this position on 2020-07-16 and 2 other members of the Management Board who might be found within the Company Staff section of this page.

Previous company's names
Origin Sciences Limited 2010-06-29
Colonix Medical Limited 2006-09-20
Colonix Limited 2003-11-17

Financial data based on annual reports

Profit & Loss
Date of Accounts	2018-11-30	2019-11-30	2020-11-30	2021-11-30	2022-11-30
Currency

Balance Sheet
Cash Bank On Hand	14 630	383 390	637 550	1 035 753	877 175
Current Assets	212 673	556 627	829 620	1 609 251	1 668 314
Debtors	198 043	173 237	192 070	573 498	791 139
Net Assets Liabilities		313 019	553 287	-586 628	1 216 446
Other Debtors	38 196	76 884	81 238	177 007	156 648
Property Plant Equipment	22 209	7 247	3 336	186 115	220 139

Other Financial Data
Accumulated Depreciation Impairment Property Plant Equipment	188 143	155 225	160 902	190 642	250 395
Amounts Owed To Group Undertakings	1	1	100	160	160
Average Number Employees During Period		13	11	12	14
Bank Borrowings Overdrafts			45 833	35 833	25 833
Corporation Tax Recoverable	155 598	93 500	108 000	392 000	630 000
Creditors	9 885 758	250 856	45 833	138 837	94 502
Current Tax For Period	-95 000	-93 500
Fixed Assets	22 210	7 248	3 437	186 276	220 300
Future Minimum Lease Payments Under Non-cancellable Operating Leases	41 580	178 500	89 844	212 828	142 450
Increase Decrease In Current Tax From Adjustment For Prior Periods	-61 413	-1 536
Increase From Depreciation Charge For Year Property Plant Equipment		15 943	5 677	44 285	59 753
Investments Fixed Assets	1	1	101	161	161
Investments In Group Undertakings Participating Interests			101	161	161
Issue Equity Instruments		6 185 310	969 811	792 500	4 860 812
Net Current Assets Liabilities	-9 673 085	305 771	595 683	-634 067	1 090 648
Number Equity Instruments Exercisable Share-based Payment Arrangement		550 000	762 500	1 445 000	2 567 500
Number Equity Instruments Forfeited Share-based Payment Arrangement		662 500
Number Equity Instruments Granted Share-based Payment Arrangement	1 912 500	50 000	1 900 000	1 380 000	820 000
Number Equity Instruments Outstanding Share-based Payment Arrangement	1 912 500	1 300 000	2 400 000	3 580 000	4 040 000
Other Creditors	9 790 925	185 260	140 062	103 004	68 669
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment		48 861		14 545
Other Disposals Property Plant Equipment		48 867		14 545
Other Taxation Social Security Payable	4 962	7 019	4 784	16 355	44 986
Profit Loss	-1 592 310	3 778 584	-729 543	-1 932 415	-3 057 739
Property Plant Equipment Gross Cost	210 352	162 472	164 238	376 757	470 534
Total Additions Including From Business Combinations Property Plant Equipment		987	1 766	227 064	93 777
Total Assets Less Current Liabilities	-9 650 875	313 019	599 120	-447 791	1 310 948
Total Current Tax Expense Credit	-156 413	-95 036
Trade Creditors Trade Payables	89 870	58 576	84 824	211 819	145 554
Trade Debtors Trade Receivables	4 249	2 853	2 832	4 491	4 491
Weighted Average Exercise Price Equity Instruments Exercisable Share-based Payment Arrangement		0	0	0	0
Weighted Average Exercise Price Equity Instruments Exercised Share-based Payment Arrangement			0
Weighted Average Exercise Price Equity Instruments Forfeited Share-based Payment Arrangement		0	0	0	0
Weighted Average Exercise Price Equity Instruments Granted Share-based Payment Arrangement		0	0	0	1
Weighted Average Exercise Price Equity Instruments Outstanding Share-based Payment Arrangement	0	0	0	0	0